siRNA Targeting Mammalian Target of Rapamycin (mTOR) Attenuates Experimental Proliferative Vitreoretinopathy

Author： Zhou Peng Zhao Ming-Wei Li Xiao-Xin Yu Wen-Zhen Bian Zong-Mei

ISSN： 0271-3683

Source： Current Eye Research, Vol.32, Iss.11, 2007-11, pp. : 973-984

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy

By Tahara Yoshihisa Sakamoto Taiji Oshima Yuji Ishibashi Tatsuro Inomata Hajime Murata Toshinori Hinton David R. Ryan Stephen J.

Current Eye Research, Vol. 19, Iss. 4, 1999-10 ,pp. : 323-329

Informa Healthcare

Access to resources Recommend Favorite

The role of retinotomy in an experimental rabbit model of proliferative vitreoretinopathy

By Goldaracena M. Begoña Garcia-Layana Alfredo Pastor J. Carlos Saornil María A. de la Fuente Francisco Gayoso Manuel J.

Current Eye Research, Vol. 16, Iss. 5, 1997-05 ,pp. : 422-427

Informa Healthcare

Access to resources Recommend Favorite

A SiRNA Targeting Vascular Endothelial Growth Factor-A Inhibiting Experimental Corneal Neovascularization

By Zuo Lei Fan Ying Wang Feng Gu Qing Xu Xun

Current Eye Research, Vol. 35, Iss. 5, 2010-05 ,pp. : 375-384

Informa Healthcare

Access to resources Recommend Favorite

Epithelial Membrane Protein-2 (EMP2) and Experimental Proliferative Vitreoretinopathy (PVR)

By Telander David G. Morales Shawn A. Mareninov Sergey Forward Krisztina Gordon Lynn K.

Current Eye Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 546-552

Informa Healthcare

Access to resources Recommend Favorite

Experimental Model for Proliferative Vitreoretinopathy by Intravitreal Dispase: Limited by Zonulolysis and Cataract

Ophthalmologica, Vol. 220, Iss. 4, 2006-06 ,pp. : 211-216

Karger

Access to resources Recommend Favorite